Philips Medical Systems Nederland B.V. recalled two operating room tables on September 3, 2025. The recall affects models 722022 and 722033 due to potential system failures. The malfunction can inhibit motorized movements, posing a risk to patients and healthcare providers.
Systems may not perform as intended due to the deterioration of certain internal components (the CMOS battery, hard disk drive, and/or power supply unit). If this deterioration occurs, motorized movements of the system will become unavailable. Manual movements of the stand (longitudinal, transversal and rotational for ceiling mounted systems and rotational for floor mounted systems) and table longitudinal movements remain available. Imaging (X-ray) functionality remains available.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter
The recall includes operating room tables with product codes 722022 and 722033. The devices were distributed worldwide, including throughout the U.S. Prices are not specified.
The systems may malfunction due to deterioration of internal components like the CMOS battery and hard disk drive. If these components fail, motorized movements will be unavailable, although manual movements and imaging functionality will remain intact.
The recall involves two units, one in the U.S. and one outside the U.S. No specific incidents have been reported, but the potential risk level is high.
Stop using the recalled operating room tables immediately. Follow the recall instructions provided by Philips and contact your healthcare provider for guidance.
For more information, contact Philips Medical Systems Nederland B.V. or visit the FDA's recall page.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.